- Home
- LXFR vs LXEO Comparison
LXFR vs LXEO Comparison
Compare LXFR & LXEO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LXFR
- LXEO
- Stock Information
- Founded
- LXFR 1898
- LXEO 2017
- Country
- LXFR United States
- LXEO United States
- Employees
- LXFR N/A
- LXEO N/A
- Industry
- LXFR Major Chemicals
- LXEO
- Sector
- LXFR Industrials
- LXEO
- Exchange
- LXFR Nasdaq
- LXEO Nasdaq
- Market Cap
- LXFR 335.4M
- LXEO 290.5M
- IPO Year
- LXFR 2012
- LXEO 2023
- Fundamental
- Price
- LXFR $12.78
- LXEO $9.58
- Analyst Decision
- LXFR
- LXEO Strong Buy
- Analyst Count
- LXFR 0
- LXEO 8
- Target Price
- LXFR N/A
- LXEO $18.38
- AVG Volume (30 Days)
- LXFR 98.8K
- LXEO 1.5M
- Earning Date
- LXFR 10-28-2025
- LXEO 11-12-2025
- Dividend Yield
- LXFR 4.07%
- LXEO N/A
- EPS Growth
- LXFR N/A
- LXEO N/A
- EPS
- LXFR 0.90
- LXEO N/A
- Revenue
- LXFR $403,800,000.00
- LXEO N/A
- Revenue This Year
- LXFR $3.12
- LXEO N/A
- Revenue Next Year
- LXFR $3.31
- LXEO N/A
- P/E Ratio
- LXFR $13.09
- LXEO N/A
- Revenue Growth
- LXFR 5.60
- LXEO N/A
- 52 Week Low
- LXFR $9.41
- LXEO $1.45
- 52 Week High
- LXFR $15.64
- LXEO $11.72
- Technical
- Relative Strength Index (RSI)
- LXFR 42.67
- LXEO 83.25
- Support Level
- LXFR $12.57
- LXEO $7.90
- Resistance Level
- LXFR $13.74
- LXEO $8.88
- Average True Range (ATR)
- LXFR 0.42
- LXEO 0.55
- MACD
- LXFR -0.09
- LXEO 0.16
- Stochastic Oscillator
- LXFR 21.19
- LXEO 97.55
About LXFR Luxfer Holdings PLC
Luxfer Holdings PLC is a manufacturer industrial company innovating niche applications in materials engineering. It focuses on value creation by using its broad array of technical know-how and proprietary technologies to help create a safe, clean, and energy-efficient world. Luxfer's high-performance materials, components, and high-pressure gas containment devices are used in defense, first response and healthcare, transportation, and general industrial applications. It focuses on product lines related to magnesium alloys, zirconium chemicals, and carbon composites. Its segments are Elektron, Gas Cylinders, and Graphic Arts. It generates the majority of its revenue from Elektron and as well as Gas Cylinders.
About LXEO Lexeo Therapeutics Inc.
Lexeo Therapeutics Inc is a clinical-stage genetic medicines company committed to transforming healthcare by applying pioneering science to fundamentally alter how diseases are treated. The company focuses on preclinical and clinical stage gene therapies, specifically hereditary and acquired diseases with high unmet needs, which represent its sole business segment.